tazobactam has been researched along with Endocarditis, Bacterial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blázquez-Gamero, D; Brañas, P; Epalza, C; Flores, M; Grau, S; Martín-Cazaña, M; Olmedilla, M | 1 |
| Bure, A; Carbon, C; Jehl, F; Mentec, H; Saleh-Mghir, A; Vallois, JM | 1 |
2 other study(ies) available for tazobactam and Endocarditis, Bacterial
| Article | Year |
|---|---|
Successful ceftolozane-tazobactam rescue therapy in a child with endocarditis caused by multidrug-resistant Pseudomonas aeruginosa.
Topics: Cephalosporins; Child, Preschool; Endocarditis, Bacterial; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome | 2019 |
Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.
Topics: Animals; beta-Lactamase Inhibitors; beta-Lactamases; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rabbits; Tazobactam | 1992 |